Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,771,186
+$26,618 QoQ
Shares Held
6,974
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#2,453
of 4,664 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Quarterback LLC holds $7,847,504 across 9 Drug Manufacturers - General names. JNJ ranks #2 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,506 | $1,806,341 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
6,974 | $1,771,186 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
26,938 | $1,552,167 | |
| 4 | NVO |
Novo Nordisk A S
|
18,626 | $892,930 | |
| 5 | AMGN |
Amgen Inc
|
1,763 | $638,417 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,856 | $366,996 | |
| 7 | ABBV |
AbbVie Inc.
|
1,261 | $317,318 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,244 | $283,506 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,771,186 | 6,974 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,744,568 | 7,137 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,465,206 | 7,080 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,313,329 | 7,083 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,104,535 | 7,231 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,254,579 | 7,565 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,507,566 | 17,339 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,807,689 | 17,325 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,948,339 | 20,172 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $3,092,772 | 19,551 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,408,468 | 21,746 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,631,014 | 10,472 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,706,345 | 10,309 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,271,465 | 8,203 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,432,808 | 8,111 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,293,321 | 7,917 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,337,537 | 7,535 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $1,321,908 | 11,086 | Shares | Sole | 2021-11-17 | |
| 2021-06-30 | $1,408,032 | 8,547 | Shares | Sole | 2021-08-11 | |
| 2020-12-31 | $1,217,334 | 7,735 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $1,051,986 | 7,066 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $993,691 | 7,066 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $722,000 | 5,506 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||